Certificate of Analysis: July_2024
Tirzepatide is a novel investigational medicine developed by Eli Lilly and Company for the treatment of type 2 diabetes. It belongs to a class of medications called dual glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists. This means it targets two different hormones involved in blood sugar regulation.
Clinical trials have shown promising results in terms of its ability to lower blood sugar levels, reduce body weight, and possibly have cardiovascular benefits. It's considered a potential advancement in diabetes treatment due to its dual action and its effectiveness in managing blood sugar levels and weight simultaneously. However, as of my last update, it might still be undergoing regulatory review or be available only in certain regions.
Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabled as a drug, food or cosmetic.
Save on Tirzepatide 10mg with a EQNO Scientific coupon
Checkmate is a savings app with over one million users that have saved $$$ on brands like EQNO Scientific .
The Checkmate extension automatically applies EQNO Scientific discount codes, EQNO Scientific coupons and more to give you discounts on products like Tirzepatide 10mg.